Information Provided By: 
Fly News Breaks for January 7, 2020
AHCO
Jan 7, 2020 | 08:43 EDT
Jefferies analyst Brian Tanquilut initiated coverage of AdaptHealth with a Buy rating and $15 price target, calling it a "top 3 player in a thematically-right DME space" where it has acted as a consolidator. He expects management to pursue more deals going forward and expects secular growth, market share gains, and service line expansion to help AdaptHealth grow revenue organically in the mid-to-high-single digit percentage range, Tanquilut tells investors.
News For AHCO From the Last 2 Days
AHCO
Apr 17, 2024 | 16:15 EDT
